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aggregation. The association of loss-of-function muta-Protein Kinases Linked
tions in parkin, DJ-1, and PINK1 with familial parkinson-to the Pathogenesis ism and nigral degeneration indicates that these gene
products are essential for the survival of dopaminergicof Parkinson’s Disease
nigral neurons. The mechanism by which loss-of-func-
tion mutations in each of these recessive parkinsonian
genes causes nigral degeneration is the focus of intense
research on the pathogenesis of parkinsonism (ShenTwo papers (by Paisa´n-Ruı´z et al. and by Zimprich et
and Cookson, 2004). As yet, there are few clues to theal.) in this issue of Neuron identify a causative gene,
normal function of PINK1 and DJ-1; PINK1 contains aLRRK2, for familial parkinsonism. Several dominantly
mitochondrial targeting motif and a protein kinase do-inherited missense mutations have been identified in
main that is highly homologous to the serine/threoninea number of families that exhibit a broad spectrum
kinases of the calcium/calmodulin family, while DJ-1of neuropathological features, including deposition of
lacks known functional domains.-synuclein and tau proteins. The LRRK2 gene is pre-
In this issue of Neuron, two new studies identify adicted to encode a large protein containing leucine-
novel gene on chromosome 12 as the PARK8 locusrich repeats and Ras/GTPase, tyrosine kinase-like,
previously linked to familial parkinsonism (Paisa´n-Ruı´zand WD40 domains.
et al., 2004; Zimprich et al., 2004). In the report by Paisa´n-
Ruı´z et al., two different missense mutations in theParkinson’s disease (PD) is the second most common
PARK8 gene (which was renamed after online publica-neurodegenerative disease, affecting up to 50% of indi-
tion LRRK2 [leucine-rich repeat kinase 2]) segregatedviduals over age 85. PD is characterized by the clinical
with disease in four Basque families (R1396G) and atriad of resting tremor, rigidity, and bradykinesia, which
fifth large family from the United Kingdom (Y1654C).typically responds to levodopa therapy. The neuropath-
Additional examination of 231 PD patients from Spainologic hallmarks of PD are loss of dopaminergic neurons
and North America, some of whom had a positive familyand deposition of cytoplasmic protein aggregates
history of PD, yielded 11 Spanish cases carrying the
termed Lewy bodies in the substantia nigra. The move-
R1396G mutation. Zimprich et al. identified missense
ment disorder in PD is thought to arise from reduced
mutations in the same two amino acid residues of the
dopaminergic input to the striatum as a result of nigral
LRRK2 gene in two large pedigrees of German-Cana-
degeneration. Parkinsonism, a clinical syndrome with
dian and probable English (residing in western Ne-
features resembling those of PD, is also characteristic
braska) origin. In the former case, the identified mutation
of a variety of distinct neurologic disorders, such as leads to an identical missense mutation (Y1699C, with
Lewy body dementia (LBD), multisystem atrophy (MSA), the different numbering owing to the inclusion of an
and progressive supranuclear palsy (PSP). These disor- additional 45 amino acids corresponding to exon 6),
ders are distinguished from PD by the presence of addi- while in the latter case a distinct mutation leads to a
tional clinical and neuropathological features, such as different substitution in the same arginine residue
the dementia and cerebral cortical Lewy bodies in LBD. (R1441C). Analysis of an additional 32 families led to the
Research on the pathogenesis of PD has been spurred identification of the R1441C mutation in an unrelated
in recent years by the identification of several genes family, as well as the identification of two further mis-
responsible for familial forms of parkinsonism (Gwinn- sense mutations (I1122V, I2020T) and a putative splice
Hardy, 2002). Missense and triplication mutations in the site mutation in three other families. In both studies, the
-synuclein gene cause autosomal-dominant (AD) famil- identified mutations segregated with disease and were
ial parkinsonism, whereas loss-of-function mutations highly penetrant. The absence of the identified nucleo-
(large deletions and truncations as well as missense tide substitutions in 1000 control chromosomes in
mutations) in the parkin, DJ-1, and PINK1 genes cause each study further argues in favor of pathogenic muta-
autosomal-recessive (AR) inheritance of parkinsonian tions rather than polymorphisms. It will be interesting
syndromes (Table 1). The identification of pathogenic to find out whether the Japanese Sagamihara kindred,
mutations in -synuclein, a major constituent of Lewy in which the PARK8 linkage was initially identified (Fu-
bodies, provides a direct link to the neuropathology of nayama et al., 2002), carries one of these identified mu-
PD and related disorders, suggesting that -synuclein tations or a distinct mutation.
deposition is relevant to the degeneration of nigral neu- The predicted product of the LRRK2 gene is a large
rons. While the clinical and neuropathological spectrum protein, LRRK2/dardarin (2527 amino acids encoded by
in kindreds bearing -synuclein mutations includes typi- 51 exons). LRRK2 and the related predicted protein
cal PD and LBD, parkin-linked cases generally exhibit LRRK1 were initially identified on the basis of genomic
selective loss of nigral neurons in the absence of Lewy and EST information as members of a novel family of
bodies, even though the clinical features of patients the tyrosine kinase-like group of protein kinases, which
bearing parkin mutations are often indistinguishable bear sequence similarity to both tyrosine and serine/
from idiopathic PD. Parkin can function as an E3 ubiqui- threonine kinases (Manning et al., 2002). The LRRK2
tin ligase, suggesting that altered protein turnover may coding sequence comprises multiple conserved do-
mains: 12 leucine-rich repeats, a Ras/small GTPase su-promote nigral degeneration independent of -synuclein
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the neuropathological heterogeneity. Affected individu-Table 1. Familial Parkinsonism
als generally exhibit either typical PD or LBD, in associa-
Locus Gene Inheritance
tion with neuronal loss and gliosis in the substantia ni-
PARK1 4q21-22 -synuclein AD gra. However, nigral degeneration was associated with
PARK2 6q25-27 parkin AR a variety of pathologic features: absence of other dis-
PARK3 2p13 ? AD
tinctive pathologic features (“pure nigral degeneration”);PARK4 4p15 ? AD
brainstem Lewy bodies, typical of PD; widespread brain-PARK5 4p14 UCH-L1 AD
stem and cortical Lewy bodies, consistent with LBD; orPARK6 1p35-36 PINK1 AR
PARK7 1p36 DJ-1 AR absence of Lewy bodies but presence of neurofibrillary
PARK8 12p11.2-q13.1 LRRK2 AD tangles, consistent with tauopathy (Funayama et al.,
2002; Paisa´n-Ruı´z et al., 2004; Wszolek et al., 2004;
Zimprich et al., 2004). Pure nigral degeneration is also
characteristic of PARK2 cases caused by parkin muta-perfamily domain, a nonreceptor tyrosine kinase-like do-
tions, whereas parkinsonism with tauopathy is charac-main, and a WD40 domain. This domain architecture
teristic of some FTDP-17 (frontotemporal dementia withhas been proposed to define a family of multifunctional
parkinsonism linked to chromosome 17) cases causedRas/GTPases, termed Roc (for Ras of complex proteins)
by tau mutations. As noted above, LBD can also be(Bosgraaf and Van Haastert, 2003). The presence of LRR
caused by -synuclein mutations. Thus, the clinical,and WD40 motifs suggests that protein-protein interac-
pathologic, and genetic heterogeneity associated withtions play an important role in the function of LRRK2,
familial parkinsonism suggests that multiple pathogenicwhich may function as a component of a multiprotein
mechanisms can lead to the central pathogenic eventcomplex. The Ras-like small GTPases (e.g., Ras, Rap1,
of nigral degeneration, which produces parkinsonianRho/Rac, Rab, and Ran) act as molecular switches regu-
phenotypes, along with variable other pathological fea-lating diverse cellular processes, including mitogenic
tures.signaling, cytoskeletal reorganization, vesicle traffick-
As these observations illustrate, neither Lewy bodying, and nucleocytoplasmic transport (Takai et al., 2001).
formation nor NFT formation are obligate events in nigralInterestingly, the tyrosine kinase-like MAPKKKs are pri-
degeneration, and mutations in a single gene (LRRK2)mary effectors of small GTPases; the presence of similar
can apparently produce nigral degeneration in the ab-domains in LRRK2 raises the possibility that its kinase
sence or presence of either of these intraneuronal aggre-activity may undergo GTP-dependent autoactivation.
gates. Nevertheless, mutations in the -synuclein andCharacterization of the predicted GTPase and kinase
tau genes are sufficient to produce familial parkinsonismactivities, their regulation, and the interaction of LRKK2
with some clinical and neuropathological heterogeneity.with specific binding proteins and substrates will likely
A central challenge for research on parkinsonism willprovide clues to its role in dopaminergic neuronal func-
be to define these multiple pathogenic mechanisms andtion and survival. Importantly, the identified mutations
their points of molecular convergence. It will be of partic-in LRRK2 all affect highly conserved residues in multiple
ular interest to determine whether and how the LRRK2domains, and in particular, the identification of two dis-
protein and its putative GTPase and tyrosine kinasetinct mutations in the same amino acid (R1441G,
activities interact with the other gene products or path-R1441C) within the GTPase domain highlights the impor-
ways thus far implicated in familial parkinsonism.tance of this arginine residue in the pathogenesis of
the disease.
In addition to LRRK2/dardarin, PINK1, which was pre- Jie Shen
viously cloned independently as BRPK, is also a protein Center for Neurologic Diseases
kinase. A BLAST homology search revealed that PINK1/ Brigham and Women’s Hospital
BRPK shares sequence homology with the N-terminal Harvard Medical School
half of the EEED8.9 gene product in C. elegans, whereas Boston, Massachusetts 02115
the C-terminal half of EEED8.9 shares sequence homol-
Selected Readingogy with human BRAP2 (BRCA1-interacting protein 2)
(Nakajima et al., 2003). The finding that PINK1/BRPK
Bosgraaf, L., and Van Haastert, P.J. (2003). Biochim. Biophys. Actaand BRAP2 homologs occur as separate domains in a
1643, 5–10.fusion protein in a lower organism suggests that the
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., andmammalian proteins interact functionally and/or physi-
Obata, F. (2002). Ann. Neurol. 51, 296–301.
cally in a common pathway (Marcotte et al., 1999).
Gwinn-Hardy, K. (2002). Mov. Disord. 17, 645–656.BRAP2 has also been named IMP (impedes mitogenic
Manning, G., Whyte, D.B., Martinez, R., Hunter, T., and Sudarsanam,signal propagation) and is a Ras-responsive E3 ubiquitin
S. (2002). Science 298, 1912–1934.
ligase (Matheny et al., 2004). Upon activation of Ras, IMP
Marcotte, E.M., Pellegrini, M., Ng, H.L., Rice, D.W., Yeates, T.O.,
is modified by autopolyubiqutination, which releases the and Eisenberg, D. (1999). Science 285, 751–753.
inhibition of Raf-MEK complex formation. Thus, PINK1
Matheny, S.A., Chen, C., Kortum, R.L., Razidlo, G.L., Lewis, R.E.,
appears to be involved in Ras/MAPK signaling. A possi- and White, M.A. (2004). Nature 427, 256–260.
ble link of LRRK2 to Ras/MAPK signaling is suggested Nakajima, A., Kataoka, K., Hong, M., Sakaguchi, M., and Huh, N.H.
by the presence of a Ras-like small GTPase domain in (2003). Cancer Lett. 201, 195–201.
LRRK2, since the MAPK cascade can function as an Paisa´n-Ruı´z, C., Jain, S., Evans, E.W., Gilks, W.P., Simo´n, J., van
effector mechanism for the action of small GTPases. der Brug, M., de Munain, A.L., Aparicio, S., Gil, A.M., Khan, N., et
al. (2004). Neuron 44, this issue, 595–600.One further point of interest in the PARK8 families is
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Shen, J., and Cookson, M.R. (2004). Neuron 43, 301–304. altered sensory processing present in pathological pain
Takai, Y., Sasaki, T., and Matozaki, T. (2001). Physiol. Rev. 81, states. The superficial dorsal horn, the main site of termi-
153–208. nation of nociceptive afferent input to the spinal cord,
Wszolek, Z.K., Pfeiffer, R.F., Tsuboi, Y., Uitti, R.J., McComb, R.D., has previously been shown to contain a high density of
Stoessl, A.J., Strongosky, A.J., Zimprich, A., Muller-Myhsok, B., Far- Ca2-permeable AMPA receptors, as identified using
rer, M.J., et al. (2004). Neurology 62, 1619–1622. kainate-induced cobalt uptake in which cobalt goes
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, through open Ca2-permeable AMPA receptors (Engel-
S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B., et al. (2004). man et al., 1999). Hartmann et al. have shown that, com-
Neuron 44, this issue, 601–607.
pared with wild-type littermates, mice lacking GluR1/A
have reduced numbers of cobalt-positive neurons,
whereas mice lacking GluR2/B have increased numbers
of cobalt-positive neurons, using this same assay. In
other words, mice lacking GluR1/A and GluR1/B have
decreased and increased numbers of Ca2-permeableAMPA Receptors Bring On the Pain
AMPA receptors in the superficial dorsal horn, respec-
tively.
The AMPA receptor-mediated component of synaptic
currents, recorded from the superficial dorsal horn, wereThe role of Ca2-permeable AMPA receptors in pain
reduced in the GluR1/A/ mice and enhanced in theprocessing has not been extensively studied. In this
GluR2/B/ mice. However, both groups of mice showedissue of Neuron, Hartmann et al. show that altering
intact nociceptive withdrawal reflexes as assessed be-the levels of these receptors has consequences for
haviorally. Latency to tail flick withdrawal from noxiousinflammatory pain hypersensitivity but not acute
heat was unaltered, and hindpaw withdrawal in re-pain processing.
sponse to noxious thermal or mechanical stimuli was
similarly unaffected. Additionally, in an in vitro prepara-In the late 1980s and early 1990s, the previously elusive
tion, activity reflecting spinal cord reflexes elicited byreceptors for the excitatory amino acid glutamate were
nociceptor stimulation was not altered. This indicatescharacterized, cloned, and intensively studied. The
that the nociceptive pathway is intact and functioningNMDA receptor was shown to be blocked by Mg2 and
in both sets of modified animals.to be permeable to Ca2. The non-NMDA receptors,
The behavioral hypersensitivity that develops follow-named the AMPA and kainate receptors, were initially
ing an inflammatory insult, however, was altered. Thebelieved to show little permeability to Ca2. At that time,
formalin test was used as one assay for such changes.the kainate receptor’s role in nervous system function
In this test, formalin injection into the hindpaw of thewas obscure, but the AMPA receptors were known as
animal results in an early (phase I) and late (phase II)the key transducers of synaptically released glutamate.
behavioral response. The phase I response reflects CTheir apparent lack of Ca2 permeability and voltage-
fiber activation due to the inflammatory insult, whereas
dependent activity made them seemingly simple to un-
the phase II response is thought to reflect central sensiti-
derstand compared to the complex NMDA receptor.
zation within the dorsal horn, in part because of its sensi-
However, it soon became clear that within the four genes
tivity to intrathecal NMDA receptor antagonists (Woolf
coding subunits of the AMPA receptor family, GluR1, and Salter, 2000). GluR2/B/ animals showed an en-
-2, -3, and -4, also called GluR-A, -B, -C, and -D, the hanced response in phase II of the formalin test. Con-
presence of GluR2/B made the multisubunit AMPA re- versely, the GluR1/A/ animals showed depressed re-
ceptors Ca2 impermeable. In the absence of GluR2/B, sponses in phase II. This suggests that altering AMPAR
AMPA receptors were permeable to Ca2 and showed an composition can modulate NMDAR-mediated increases
inwardly rectifying dependence on membrane potential in central excitability. Consistent with this observa-
(Verdoorn et al., 1991). These Ca2-permeable AMPA tion, the GluR1/A animals did not show elevated phos-
receptors are now known to be expressed at synapses phorylation of extracellular activated MAP Kinases1/2
between a variety of neurons throughout the central (ERK1/2) in lamina I following high-frequency stimulation
nervous system, including the spinal cord dorsal horn— of high-threshold C fibers, an in vitro correlate of the
the first stage of central somatosensory processing. persistent nociceptor activation induced by an inflam-
Ca2-permeable AMPA receptors have proven notori- matory agent like formalin, whereas GluR2/B/ animals
ously difficult to study. Because they are defined by the showed normal elevations.
absence of GluR2/B, the only certain way to demon- These experiments clearly show that the composition
strate their active presence on the surface of a neuron of AMPA receptors expressed at synapses in the pain
is by functional assay. Pharmacology of the receptors pathway strongly influences the generation of hypersen-
is also limited because the compounds that block them, sitivity in inflammatory pain models. The correlation be-
including polyamines such as Joro spider toxin, are tween altered central sensitization and the numbers of
open channel blockers and so are complicated to use. neurons expressing Ca2-permeable AMPA receptors,
In addition, these compounds are nonselective in that as shown by changes in cobalt loading, suggests that
they also block Ca2-permeable kainate receptors. this family of receptors can shift the balance of long-
In this issue of Neuron, Hartmann et al. (2004) have lasting changes in excitability within the dorsal horn. To
instead used a genetic approach to investigate the role understand the implications of this observation, how-
of Ca2-permeable AMPA receptors in the spinal cord ever, a great deal more investigation will be needed.
This is because not only can AMPA receptor type influ-dorsal horn in normal nociceptive processing versus the
